A Science and Technology Blog
A realistic (but very optimistic) timeline from the start of Phase-1 to the completion of Phase-3 could be about six to nine months (if all goes exactly according to plan),…
A day after serious concerns were raised, ICMR has reversed its stand. It says its decision to fast-track the trial process was only to cut the red-tape and not to…
On July 2, ICMR had sent a threatening letter sent to principal investigators at 12 sites to complete the Phase-1/phase-2 trail of India’s first indigenous COVID-19 vaccine by August 15.…
With the pandemic raging across many countries and the demand for a safe, efficacious vaccine being huge, availability of an indigenous vaccine will mean guaranteed availability for Indians, while a…
Bharat Biotech’s typhoid conjugate vaccine shows nearly 82% efficacy at 12 months in a Phase-3 trail carried out in Nepal. It can be be given to babies as young as…
Bharat Biotech International Ltd in Hyderabad will start a Phase I clinical trial of Zika virus vaccine (MR 766) in two centres in India next month. The inactivated vaccine being…
The Hyderabad-based Bharat Biotech’s killed (inactivated) Zika virus vaccine using an African strain (MR 766) has shown 100% efficacy against mortality and disease in animal studies. A ‘killed virus vaccine’…
A Phase III randomised, double-blind, placebo-controlled trial of 116E rotavirus vaccine undertaken in infants at three centres in India was found to be safe. It had modest efficacy of 56.4…
